Sentence examples for multiple sclerosis cohort from inspiring English sources

Rotstein, D. L., Healy, B. C., Malik, M. T., Chitnis, T. & Weiner, H. L. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.

The multiple sclerosis cohort included nine acute cases, who died within 1 year of disease onset (Table 1) (Marburg, 1906).

We previously reported biopsied multiple sclerosis patients have a similar clinical course and prognosis compared with a population-based multiple sclerosis cohort (Pittock et al., 2005).

In vivo control data were age matched to the post-mortem multiple sclerosis cohort as far as possible, to within a maximum of 4 years.

The multiple sclerosis cohort included seven cases of acute multiple sclerosis (Marburg, 1906), who died within 1 year after disease onset (Table 1).

Interestingly, EDSS in biopsied multiple sclerosis cases with a disease duration >10 years was significantly less compared with the prevalence multiple sclerosis cohort matched for disease duration >10 years, (1.5 versus 3.5 P < 0.001).

Thus, our findings are robust, and characteristics such as gender distribution, age of onset and type of multiple sclerosis distribution of our cohort are similar to those reported in most other multiple sclerosis cohorts.

A 10-Item Neuro-Ophthalmic Supplement to the NEI-VFQ-25 was designed using multiple sclerosis cohorts to capture symptoms relevant to neurologic disease in a more sensitive manner (Ma et al., 2002; Raphael et al., 2006).

Although we observed that EDSS at last follow-up was slightly higher in the biopsy cohort compared with the multiple sclerosis prevalence cohort when matched for disease durations between 0 5 and 5 10 years, it is well recognized that EDSS scores in the low range are less reproducible and a 1 point increase in EDSS when <4 is of lesser clinical importance than a 1 point rise in EDSS ≥6.

Since these are overlapping but not identical populations, we compared disability (EDSS) at last follow-up in our study cohort with established disability data from the OC multiple sclerosis prevalence cohort, stratified for disease duration.

Runmarker, B. & Andersen, O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up.